BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,928 | -0.2% | 2,390,948 | -0.8% | 0.05% | -1.9% |
| Q2 2023 | $16,968 | -29.5% | 2,410,190 | -16.5% | 0.05% | -36.1% |
| Q1 2023 | $24,084 | -26.7% | 2,887,739 | +0.9% | 0.08% | -29.7% |
| Q4 2022 | $32,860 | -99.9% | 2,862,387 | +25.5% | 0.12% | +4.4% |
| Q3 2022 | $28,740,000 | +29.4% | 2,280,953 | +8.7% | 0.11% | +32.9% |
| Q2 2022 | $22,211,000 | -18.0% | 2,099,327 | +26.1% | 0.08% | -9.6% |
| Q1 2022 | $27,077,000 | +3.4% | 1,665,256 | -11.9% | 0.09% | +6.8% |
| Q4 2021 | $26,193,000 | +13062.3% | 1,891,160 | +11482.3% | 0.09% | +4300.0% |
| Q4 2014 | $199,000 | – | 16,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |